Ausgabe 3/2009
Inhalt (15 Artikel)
Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy
Constantin N. Baxevanis, Sonia A. Perez, Michael Papamichail
Modified tumour antigen-encoding mRNA facilitates the analysis of naturally occurring and vaccine-induced CD4 and CD8 T cells in cancer patients
Ashley J. Knights, Natko Nuber, Christopher W. Thomson, Olga de la Rosa, Elke Jäger, Jean-Marie Tiercy, Maries van den Broek, Steve Pascolo, Alexander Knuth, Alfred Zippelius
Chordoma and chondrosarcoma gene profile: implications for immunotherapy
Joseph H. Schwab, Patrick J. Boland, Narasimhan P. Agaram, Nicholas D. Socci, Tianhua Guo, Gary C. O’Toole, Xinhui Wang, Elena Ostroumov, Christopher J. Hunter, Joel A. Block, Stephen Doty, Soldano Ferrone, John H. Healey, Cristina R. Antonescu
Generation of a human IgM monoclonal antibody directed against HLA class II molecules: a potential agent in the treatment of haematological malignancies
Belén Díaz, Irene Sanjuan, Francisco Gambón, Carmen Loureiro, Susana Magadán, África González–Fernández
TIMP-1-GPI in combination with hyperthermic treatment of melanoma increases sensitivity to FAS-mediated apoptosis
Roghieh Djafarzadeh, Valeria Milani, Nicole Rieth, Irene von Luettichau, Petra S. Skrablin, Monika Hofstetter, Elfriede Noessner, Peter J. Nelson
A prostate cancer vaccine comprising whole cells secreting IL-7, effective against subcutaneous challenge, requires local GM-CSF for intra-prostatic efficacy
Caroline Schroten-Loef, Corrina M. A. de Ridder, Suzanne Reneman, Marije Crezee, Angus Dalgleish, Stephen M. Todryk, Chris H. Bangma, Robert Kraaij
Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression
Jennifer A. Wargo, Paul F. Robbins, Yong Li, Yangbing Zhao, Mona El-Gamil, Diana Caragacianu, Zhili Zheng, Julie A. Hong, Stephanie Downey, David S. Schrump, Steven A. Rosenberg, Richard A. Morgan
Total HLA class I loss in a sarcomatoid renal carcinoma cell line caused by the coexistence of distinct mutations in the two encoding β2-microglobulin genes
Chin-Hsuan Hsieh, Ya-Jan Hsu, Chien-Chung Chang, Hsin-Chun Liu, Kun-Lung Chuang, Cheng-Keng Chuang, See-Tong Pang, Kenichiro Hasumi, Soldano Ferrone, Shuen-Kuei Liao
cDNA clone, prokaryotic expression and purification of human interleukin-13 receptor {alpha}2 chain
Wenqiao Yu, Zhipeng Su, Zhebao Wu, Xiaochun Mao, Weiming Zheng, Yanjun Zeng
Targeting 11q23 positive acute leukemia cells with high molecular weight-melanoma associated antigen-specific monoclonal antibodies
Allison S. Drake, Michael T. Brady, Xin Hui Wang, Sheila J. N. Sait, Justin C. Earp, Sampa Ghoshal (Gupta), Soldano Ferrone, Eunice S. Wang, Meir Wetzler
Aberrant expression of the hematopoietic-restricted minor histocompatibility antigen LRH-1 on solid tumors results in efficient cytotoxic T cell-mediated lysis
Ingrid M. Overes, T. Henriëtte Levenga, Johanna C. M. Vos, Agnes van Horssen-Zoetbrood, Robbert van der Voort, Pieter H. De Mulder, Theo M. de Witte, Harry Dolstra
Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer
Masahiro Ohara, Yoshiyuki Yamaguchi, Kazuo Matsuura, Shigeru Murakami, Koji Arihiro, Morihito Okada
Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer
Ninke Leffers, Marloes J. M. Gooden, Renske A. de Jong, Baukje-Nynke Hoogeboom, Klaske A. ten Hoor, Harry Hollema, H. Marieke Boezen, Ate G. J. van der Zee, Toos Daemen, Hans W. Nijman
Potential immunologic effects of statins in cancer following transplantation
J. E. Fildes, S. M. Shaw, S. G. Williams, N. Yonan
p27 and salivary cancer
Ofer Ben-Izhak, Sharon Akrish, Shlomit Gan, Rafael M. Nagler